Interview to Link to Leaders by Miguel Garcia, CEO of Technophage

Interview to Link to Leaders by Miguel Garcia, CEO of Technophage

In the past few months, and due to the recently initiated Phase I/IIa Clinical Trial of the bacteriophage cocktail TP-102, which has been entirely developed in the company for the treatment of diabetic foot ulcers infected by Pseudomonas aeruginosa, Acinetobacter...
Technophage is hiring a Head of Neurosciences

Technophage is hiring a Head of Neurosciences

TechnoPhage is hiring a Head of Neurosciences with a strong scientific background to lead a team dedicated to the research and development of new medicines in the Neurosciences and Ophthalmology therapeutic areas.  Main responsibilities: Research and development of...
Technophage featured at TV show ‘Exame Informática’

Technophage featured at TV show ‘Exame Informática’

Technophage has been recently featured in the TV show ‘Exame Informática’. In this piece, you can quickly learn a bit more about our bacteriophage cocktail TP-102, also gaining an opportunity to a virtual tour of our GMP production unit. TechnoPhage...